Board Review: Anemia Greg Radin 7/9/2013. Anemia Definition: Insufficient erythrocytes to carry O2 to peripheral tissues Symptoms: Tachycardia, DOE, decreased.

Slides:



Advertisements
Similar presentations
RBC Morphology and Cases
Advertisements

A NAEMIA ’ S Shannon and Rick. A NAEMIA A Hb deficit of whole-body circulating blood volume Dependant on age and gender Creates the risk of tissue hypoxia.
Paolo Aquino PGY-I January 2005 VA Hospital
Approach to Anemia - Summary
AN APPROACH TO THE ANEMIC PATIENT Martin H. Ellis MD Meir Hospital 2007.
Anti-Anemia Agents Broyles Chapter 22 Lehmkuhl, 2009.
Sickle Cell Anemia Roxbury Community College ADN 253 Honors Presentation Adanna Uwandu, Shadia Laurent, Salwa Said 05/01/07.
Clinical pathology department SCU
HEREDITARY SPHEROCYTOSIS (HS). Introduction Hereditary spherocytosis is a class of hemolytic anemia. The disease occurs due to an intrinsic “membrane.
Alterations of Erythrocyte Function
CLUES TO THE DIAGNOSIS IN ANEMIA PRINCIPLES 4 Anemia is not a disease 4 There is usually a cause 4 investigation should be logical 4 Start with CBC and.
ANEMIA Pamela L. Charity, MD, FHM Medical University of South Carolina May 23, 2013.
Anemia Dr. Meg-angela Christi M. Amores. What is Hematopoeisis? It is the process by which the formed elements of the blood are produced Erythropoeisis:
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
MLAB Hematology Keri Brophy-Martinez
Mediterranean Anemia-Thalassemia
Life of a Red Blood Cell Erythroid precursors undergo 4-5 divisions in marrow, extrude nucleus, become reticulocytes, enter peripheral blood, and survive.
Tessa Bandhan. Question 1 A 3 year old girl known to have sickle cell disease (Hb SS) presents to the Emergency Room with a 2 day history of weakness.
Chemotherapy/ Biotherapy for Hematology Disease Processes.
Week 2: Hemolytic Anemia
Sickle Cell Disease Joshua Falto PAs-IV. General Considerations PATHOPHYSIOLOGY 1.A single DNA base change leads to an amino acid substitution of valine.
Week 1: Microcytosis Anemia classification Anemia classification Micro-Hypo anemia Micro-Hypo anemia CBC and histogram CBC and histogram IDA IDA Fe metabolism.
Anemias Clinical Pharmacy.
Dr. Sarah Zahid PHARMACOLOGICAL MANAGEMENT OF IRON DEFICIENCY ANEMIA.
Splenectomy in Hematologic Disorders
Anaemia By Jeeves.
Chapter 11 The Red Blood Cell and Alterations in Oxygen Transport
Laboratory diagnosis of Anemia
ANEMIA - PART II Anemia of Chronic Inflammation BY: Zorawar Noor 4/21/2014.
 The term is derived from ancient Greek ” bloodlessness “it is defined as a low haemoglobin concentration that is below the normal range appropriate.
Introduction to Haematology! Elliot Catchpole PCMD Starting with anaemias!
Anaemia. Definition decreased haemoglobin concentration a decrease in normal number of red blood cells decreased haematocrit.
MLAB 1415: Hematology Keri Brophy-Martinez
MLAB 1415-Hematology Keri Brophy-Martinez Chapter 14: Introduction to Hemolytic Anemias.
Haemolytic Anaemia Elliot Catchpole PCMD.
Hemolytic anemia Excessive destruction of red cells Acute Hemolytic anemia Chronic Hemolytic anemia Congenita l Acquired : Immune Non-immune.
COMMON ANEMIAS Haematology Dr. Janis Bormanis Common anemias 4 Iron deficiency 4 Megaloblastic anemias 4 Secondary anemias to chronic diseases Anemia.
Clinical Application for Child Health Nursing NUR 327 Lecture 3-D.
Anemia Kristine Krafts, M.D.. Background facts about blood Anemia: general information Anemia: specific types Anemia Outline.
Main symptoms and syndromes of patients with different variants of anemia.
Red blood cell disorders / Anemia laboratory
Laboratory evaluation of erythrocyte RBC Haemoglobin Packed cell volume MCV MCH MCHC RDW Reticulocyte Blood film Quantitative description of erythropoiesis.
Nada Mohamed Ahmed , MD, MT (ASCP)i
Hemolytic anemias.
 The term is derived from ancient Greek ” bloodlessness “it is defined as a low haemoglobin concentration that is below the normal range appropriate.
CLASSIFICATION OF ANEMIA
MLAB 1415: Hematology Keri Brophy-Martinez
Blood Disorders and Diseases -Diagnosed by a Blood Count Test - Caused by inheritance, environmental factors, poor diet, old age.
Diagnostic Approaches To Anemia 1. Is the patient anemic ? 2. How severe is the anemia ? 3. What type of anemia ? 4. Why is the patient anemic? 5. What.
Approach to Anemia Sadie T. Velásquez, M.D.. Objectives.
Anemia Presented by M.A. Kaeser, DC Fall 2009
Hemoglobin Disorders Sickle cell anemia and Thalassemias Prepared by : Ahmed Ayasa Supervised by :Dr. Abdullateef Al Khateeb 1.
Nada Mohamed Ahmed, MD, MT (ASCP)i. Objectives Intoduction Definition Classification Intravascular &extra vascular hemolysis Signs of hemolytic anemias.
Anemia of chronic disease is a hypoproliferative ( بالتدريج) anemia associated with chronic infectious or inflammatory processes, tissue injury, or conditions.
ANEMIA - PART I Overall Approach and Iron Deficiency Anemia BY: Zorawar Noor 4/21/2014.
MLAB Hematology Keri Brophy-Martinez
Department of Pathology. Iowa Anemia Cases Case Analyses by Dr. Schneider Tuesday, October 11, 2011 and Thursday October 13, 2011.
Classification of Anaemia
Acquired Hemolytic Anemias
1 COLLEGE OF HEALTH SCIENCES, DEPARTMENT OF BIOMEDICAL LABORATORY SCIENCE Chapter 20. Erythrocytic disorders.
Approach to Anemias. Objectives At the end of this session you should be able to: describe history and physical examination findings pertinent to anemia.
MLAB Hematology Keri Brophy-Martinez
MLAB Hematology Keri Brophy-Martinez
IMMUNE HEMOLYSIS Definition : red cell life span is shortened because abnormalities in the components of the immune system are specifically directed against.
MLAB 1415-Hematology Keri Brophy-Martinez
Case Summary John a 4 year old boy ,complains of
A 24- year- old woman presented to her primary-care physician for evaluation of new tea –colored urine noticed intermittently over the past five days.
Approach to Haemolysis
Red Blood Cell Disorders
RED BLOOD CELLS (RBCs) Prof. Dr. Salwa Saad.
Presentation transcript:

Board Review: Anemia Greg Radin 7/9/2013

Anemia Definition: Insufficient erythrocytes to carry O2 to peripheral tissues Symptoms: Tachycardia, DOE, decreased exercise tol, pallor  depend on severity and acuity Low O2 in kidney  EPO release  RBC production in bone marrow

Approach to Anemia 3 mechanisms: – Blood loss – Hemolysis – Underproduction Retic count will be low in underproduction, high in blood loss or hemolysis – Be careful w/ low retic count in the elderly

?elevated LDH, indirect bili ?Low haptoglobin HEMOLYSIS Review risk factors Review Smear… UNDERPRODUCTION

Hemolytic anemia Membrane defects – Hereditary spherocytosis Enzyme deficiencies – G6PD deficiency Hemoglobinopathy – Sickle cell Immune hemolysis – Cold, warm, drug induced Mechanical: – Intravascular foreign body (ie mechanical valve) – Repeated trauma (“march hemolysis”) – Malaria/babesia – microangiopathy

?elevated LDH, indirect bili ?Low haptoglobin HEMOLYSIS Review risk factors Review Smear… UNDERPRODUCTION MCV Review Smear… Review risk factors?

Hypoproliferative anemias Bone marrow bx may be helpful

77M presents with 1 year fatigue & DOE, 8 weeks substernal exertional CP Vitals: T /78 HR 118, RR 17 Pale conjunctiva, summation gallop, bibasilar crackles Hb 5.4, MCV 58 RDW 25 WBC 6.4, Plt 154 Smear… Cause of anemia? A) G6PD deficiency B) Iron deficiency C) Myelofibrosis D) TTP

Most likely diagnosis is iron deficiency. – Ferritin <15 highest diagnostic accuracy – High RDW – May have thrombocytosis (benign) – BM bx for stainable iron is gold standard (rarely necessary) Smear: variations in erythrocyte size and shape (anisopoikilocytosis) and increased central pallor. Pt’s may have symptoms of iron-deficiency without anemia – Fatigue, irritability, headache, pica Treatment: PO iron salts – Take on an empty stomach (absorbtion inhibited by antacids, abx, cereals dietary fibers – Expect reticulocytosis in 7-12 days, Hb increase in several weeks Try stopping iron after 3-6 months – only use IV if unable to absorb, failure of treatment, or on HD Must look for source of blood loss (menstrual, colon CA)

22F recently diagnosed with SLE manifesting as painful joints, malar photosensitive rash, oral aphthous ulcers, and a positive antinuclear antibody and anti-Smith abs. Normal menses Meds: hydroxychloroquine and a multivitamin. Vitals: 37.2 °C (99.0 °F), BP 126/78, HR 88/min, RR 17/min. BMI is 20. malar rash and thinning hair, no joint abnormalities, oral lesions, pericardial or pleural rubs, or heart murmurs. Hb 8.2 WBC 3.9 Iron 18, TIBC 180, Ferritin 556 Cr 1.0 Smear… Cause of anemia? A) inflammatory anemia B) iron deficiency C) MAHA D) Warm ab-associated hemolysis

The patient has inflammatory anemia. Initially normocytic and normochromic but can become hypochromic and microcytic over time. Reticulocyte count: low Iron: low or normal TIBC: low Ferritin: high Smear: normal or may show microcytic hypochromic erythrocytes as in iron deficiency, not diagnostic Pathophysiology: elevated hepcidin levels that develop in response to inflammatory cytokines, including interleukin-1, interleukin-6, and interferon decreases iron absorption from the gut and the release of iron from macrophages Treatment: treat underlying process

87M seen for f/u of 8 months asymptomatic anemia PMH: HTN, HL Meds: lisinopril, atorvastatin, ASA 81 Vitals: T 98.0 BP 137/78, HR 88, RR 17 BMI 19 Exam: +S4, otherwise normal Hb 11.4 WBC 6.2, Plt 225 MCV 90, Retic 0.8% Iron 78, TIBC 356 Ferritin 187 Creatinine 1.5 Smear: normocytic, normochromic anemia Most likely cause? A) old age B) inflammatory C) iron deficiency D) kidney disease

Anemia of kidney disease Reduced EPO production due to renal cortical loss Onset around GFR of 60 Dx: rule out other causes of anemia – Consider measuring EPO level if uncertain Tx: EPO-stimulating agent if needed after correction of other factors Anemia is always pathologic even if elderly

Primarily occurs in renal peritubular capillary endothelium Liver takes over at a lower Hb setpoint in ESRD

29F college student at PCP to establish care Full-time college student, runs 3 miles twice weekly, but complains of mild fatigue in the evening. PMH: hereditary sperocytosis (onset at age 10) Meds: folate Vitals: T97.4, BP 133/62, HR 68, RR 18 Exam: scleral icterus, no adenopathy, normal heart/lungs. Spleen palpable below the costal margin Hb: 11.2 (  yrs ago) WBC 5.9 Plt 172 MCV 103, Retic 3.4% Abd US mild splenomegaly, no gallstones Treatment? A) Cholecystectomy B) corticosteroids C) splenectomy D) supportive care

Hereditary spherocytosis Pathophys: defect in structural RBCs proteins. Most common ankyrin, but also spectrin, band 3, band 4.2 – RBCs trapped and destroyed by the spleen DX: – Family hx (autosomal dominant, may be sporadic) – Osmotic fragility test: increased RBC fragility in hypotonic saline – Consider Coombs test—spherocytes seen in autoimmune hemolysis Clinical course: varies from asymptomatic to severe anemia Complications: leg ulcers, pigmented gallstones If mild, no treatment necessary Splenectomy: curative Prophylactic cholecystectomy at time of splenectomy controversial in pts WITH gallstones

87F with CC: 6 months numbness and tingling in her feet Eats a normal diet, no ETOH T normal, BP 127/85 HR 98 RR 28 BMI 20 Exam: pale conjunctivae, +icterus, decreased vibratory sensation in her toes. Finger and toenails normal. Hb: 6.9 WBC 3.9 Plt 49 T bili 4.9 LDH 520 MMA elevated, HC elevated Vitamin B12: 224 Smear… Treatment? A) oral B12 B) oral folate C) parenteral B12 D) parenteral folate

B12 deficiency Dx: elevated HC, MMA (B12 level may be normal) – Contrast with folate def., only HC elevated, no neurotoxicity Elevated LDH and indirect hyperbili due to ineffective erythropoesis, intravascular hemolysis Testing for etiology no longer important as tx the same. Smear: macrocytosis, hypersegmented neutrophils (>5 lobes) Lack of vibratory sense and paresthesia  weakness, spasticity, paraplegia Most common cause: malabsorbtion Treatment: high dose PO B12 ( mcg daily), equivalent to parenteral

17F here for f/u of microcytic anemia identified on routine CBC 3 weeks ago Otherwise healthy, no significant PMH or FH Med: OCP Vitals: BP 117/78 HR 88 RR 17 BMI 19 Exam: Conjunctival pallor, otherwise normal Hb 11.6 WBC 5.4 Plt 213 MCV 60, RDW 15, RBC count 5.5 x10^6 Retic Count: 2.3% Dx? A) hereditary spherocytosis B) iron deficiency C) sideroblastic anemia D) B-thalassemia trait

Thalassemias Due to abnormalities in the globin-producing genes. May be difficult to distinguish from iron-deficiency, also consider lead poisoning RBC indices: microcytic anemia, normal or increased RBC count. Mentzer index: MCV/RBC count. If <13, usually assoc w/ B-thal (our pt = 11) Target cells, microcytosis, hypochromia. Hemoglobin electrophoresis: – Beta: decreased HbA, increased Hb A2 and F – Alpha: normal in adults (no alternative a-globin) Severity of anemia depends on amt of synthesis of affected globin gene. Tx: transfusions as needed, iron chelation, HSCT

15M seen in ED for subacute fatigue, SOB, lethargy. 2 weeks fever, arthralgia which improved this week. Sick contact: cousin PMH: Hb SS (infrequent pain crises, no CVA or acute chest). Immunizations UTD Meds: folate 2mg/d VS: T 96.4, BP 96/55, HR 114, RR 22 Exam: pale, lethargic No rash, normal heart and lungs, no adenopathy or splenomegaly CXR normal 25

Diagnosis? A) aplastic crisis B) hyperhemolytic crisis C) megaloblastic crisis D) splenic sequestration crisis

Causes of acute worsening of chronic anemia Aplastic crisis: Usually due to Parvovirus B19, which supresses RBC production. – can confirm dx by anti-parvovirus IgM or PCR for parvo – Low retic count Hyperhemolytic crisis: high retic count (rare) Megaloblastic crisis: folate deficiency in pts with high RBC turnover (pregnancy, rapid growth, hemolytic anemia) Splenic sequestration crisis: splenic vasoocclusion and pooling of blood. – Rapid drop in Hb, high retic count – Rapidly enlarging spleen, LUQ pain

55M presents w/ 2 months L chest pain, SOB, diffuse joint pain, hematuria, LE swelling Healthy, lifts weights and jogs 3x weekly PMH: sickle cell trait, HTN, HL Meds: HCTZ, simva VS: normal, Exam normal Hb 14.2, WBC 8.6 Plt 239 MCV 85, Retic 1.9% Hb electrophoresis Hb A 59%, Hb S 39% Hb F 2% Smear, ECG, CXR all normal Which symptoms can be attributed to sickle cell trait? A) hematuria B) CP C) diffuse joint pain D) leg swelling E) shortness of breath

Sickle cell trait Benign condition with normal CBC Complications: hematuria (common, probably due to renal papillary necrosis), renal medullary CA, VTE, splenic rupture Seek alternative explanations for other symptoms in sickle cell trait

32M with fatigue, dyspnea, lethargy, yellow eyes x1 week PMH: MRSA cellulitis successfully treated with 14 days TMP/SMX completed yesterday. VS: T 98.4, BP 103/53, HR 112, RR 16 Exam: scleral icterus, tachycardia, otherwise normal Hb 9.6, WBC 8.9 Plt 259 MCV 104 (  85 3 years ago), retic 6.4% Smear… Diagnosis? A) cold agglutinin disease B) G6PD deficiency C) hereditary spherocytosis D) sickle cell disease E) thalassemia

G6PD deficiency Acute hemolytic episode after oxidant drug such as bactrim (dapsone, primaquine, nitrofurantoin) Smear shows bite cells Heinz body: denatured oxidized hemoglobin (special stain) Tx: withdraw offending agent Board trickery: Don’t check G6PD level during acute crisis (increased retic fraction, retics have more of the enzyme) – Check in a few months

43M p/w 2 days severe abd pain. PMH: recent dx of pancytopenia FH: negative Med: multivitamin VS: 97.2, BP 143/69, HR 86, RR 12 Exam: jaundice, no splenomegaly, otherwise normal Hb 10.4, WBC 3.4, Plt 89 Haptoglobin: 0, LDH 775, T/D bili 2.8/0.4 Retic count 7% CBC and LFTs 1 year ago were normal CT A/P: mesenteric vein thrombosis, no adenopathy or splenomegaly. Next diagnostic step? A) Direct coombs test B) Factor V Leiden assay C) Flow cytometry for CD55 and CD59 D) lupus anticoagulant and anti cardiolipin antibody assay

Parosysmal nocturnal hemoglobinuria Primary acquired stem cell disorder, – RBCs or WBCs lacking glycophosphatidalinosital-anchored surface proteins ie CD55 or CD 59 – Protect cells against compliment mediated destruction Signs/Symptoms: hemolytic anemia, thromboses at atypical locations, esophageal spasm, erectile dysfunction, pulmonary HTN – Thrombosis is a sign of more aggressive disease Dx: flow for CD55/59 Tx: anticoagulate for thrombosis – ?steroids – eclizumab (anti-C5) some benefit Increased risk of meningococcal infection – Immunosupressives +/- HSCT if severe

56M seen in ED for 4 weeks progressive fatigue, DOE, CP with moderate exertion. Unable to work (construction worker) FH/PMH/Meds: none significant VS: T98.2, BP 123/69 HR 98 RR 16 Exam: scleral icterus, no adenopathy, +splenomegaly Hb 8.1, WBC 4.9, Plt 159 Retic 5.4% Coombs test: IgG strong positive, C3 weak positive Smear… Dx? A) Cold agglutinin disease B) G6PD deficiency C) hereditary spherocytosis D) TTP E) Warm autoimmune hemolytic anemia

Warm: IgG antibodies bind to Rh antigens, ab-coated RBCs removed by spleen. – optimum binding at T99.0, Tx: steroids first-line (2/3 respond) – Splenectomy, rituximab, immunosupressives Cold: IgM antibodies bind to RBC antigens I or i. Abs fix compliment leading to intravascular lysis – Maximal activity at 4 Celsius – Usually a clonal B-cell disorder Tx: cold avoidance -chlorabmucil or cyclophosphamide, rituximab -plasmapheresis if acute/severe -steroids and splenectomy unhelpful Autoimmune hemolytic anemia

Most common drug in 2012: cephalosporins